Complications after transrectal ultrasound guided biopsies in screening for prostate cancer with PSA followed by MRI - results from the Goteborg prostate cancer screening 2 trial

被引：0
|
作者：
Kohestani, K. [1 ]
Godtman, Arnsrud R. [1 ]
Assadi, A. [1 ]
Eriksson, K. [1 ]
Stranne, J. [1 ]
Wallstrom, J. [2 ]
Hellstrom, M. [2 ]
Hugosson, J. [1 ]
机构：
[1] Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Dept Urol, Gothenburg, Sweden
[2] Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Dept Radiol, Gothenburg, Sweden
来源：
EUROPEAN UROLOGY | 2022年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0609
引用
收藏
页码：S910 / S911
页数：2
相关论文
共 50 条
  • [1] The value of systematic biopsies in screening for prostate cancer with PSA followed by MRI - results from the GOTEBORG prostate cancer screening 2 trial
    Kohestani, K.
    Godtman, Arnsrud R.
    Axcrona, U.
    Egevad, L.
    Hellstrom, M.
    Khatami, A.
    Pihl, C-G
    Stranne, J.
    Wallstrom, J.
    Mansson, M.
    Carlsson, S., V
    Hugosson, J.
    EUROPEAN UROLOGY, 2022, 81 : S565 - S565
  • [2] Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Goteborg prostate cancer screening 2 trial
    Wallstrom, Jonas
    Geterud, Kjell
    Kohestani, Kimia
    Maier, Stephan E.
    Mansson, Marianne
    Pihl, Carl-Gustaf
    Socratous, Andreas
    Arnsrud Godtman, Rebecka
    Hellstrom, Mikael
    Hugosson, Jonas
    EUROPEAN RADIOLOGY, 2021, 31 (11) : 8692 - 8702
  • [3] Bother during screening for prostate cancer with PSA followed by MRI and transrectal biopsies
    Godtman, Arnsrud R.
    Pettersson, C.
    Kollberg, Stinesen K.
    Wallstrom, J.
    Mansson, M.
    Hellstrom, M.
    Hugosson, J.
    EUROPEAN UROLOGY, 2022, 81 : S550 - S551
  • [4] Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial
    Jonas Wallström
    Kjell Geterud
    Kimia Kohestani
    Stephan E. Maier
    Marianne Månsson
    Carl-Gustaf Pihl
    Andreas Socratous
    Rebecka Arnsrud Godtman
    Mikael Hellström
    Jonas Hugosson
    European Radiology, 2021, 31 : 8692 - 8702
  • [5] Prostate Cancer Screening with Magnetic Resonance Imaging: Results from the Second Round of the Goteborg Prostate Cancer Screening 2 Trial
    Wallstrom, Jonas
    Geterud, Kjell
    Kohestani, Kimia
    Maier, Stephan E.
    Pihl, Carl-Gustaf
    Socratous, Andreas
    Stranne, Johan
    Arnsrud-Godtman, Rebecka
    Mansson, Marianne
    Hellstrom, Mikael
    Hugosson, Jonas
    EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (01): : 54 - 60
  • [6] Complication rates of 6272 transrectal, ultrasound (TRUS) guided biopsies of the prostate: Results from the Tyrol PSA screening study
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 154 - 154
  • [7] Complication rates of 7074 transrectal, ultrasound (TRUS) guided biopsies of the prostate: Results from the tyrol PSA screening project
    Horninger, W.
    Pelzer, A. E.
    Bektic, J.
    Achleitner, R.
    Frauscher, F.
    Pallwein, L.
    Schafer, G.
    Mocker, H.
    Bartsch, G.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 121 - 121
  • [8] Complication rates of 7074 transrectal, ultrasound (TRUS) guided biopsies of the prostate: Results from the tyrol PSA screening project
    Hominger, Wolfgang
    Pelzer, Alexandre E.
    Bektic, Jasmin
    Achleitner, Regina
    Frauscher, Ferdinand
    Pallwein, Leo
    Schaefer, Georg
    Brunner, Andrea
    Klocker, Helmut
    Bartsch, Georg
    JOURNAL OF UROLOGY, 2007, 177 (04): : 651 - 651
  • [9] Results after Four Years of Screening for Prostate Cancer with PSA and MRI
    Hugosson, Jonas
    Godtman, Rebecka Arnsrud
    Wallstrom, Jonas
    Axcrona, Ulrika
    Bergh, Anders
    Egevad, Lars
    Geterud, Kjell
    Khatami, Ali
    Socratous, Andreas
    Spyratou, Vasiliki
    Svensson, Linda
    Stranne, Johan
    Mansson, Marianne
    Hellstrom, Mikael
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (12): : 1083 - 1095
  • [10] Prostate cancers detected in the PSA interval 1.8-3 ng/mL - results from the Goteborg 2 prostate cancer screening trial
    Billig, Moller F.
    Mansson, M.
    Wallstrom, J.
    Hellstrom, M.
    Hugusson, J.
    Godtman, Arnsrud R.
    EUROPEAN UROLOGY, 2023, 83
12345